Clinical Trials Browser

Phase 1 × amrubicin × Other solid neoplasm × Clear all

NCT00915083 2019-11-01

A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors.

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors